Clinical Trials Browser

Phase 2 × carotuximab × 90 days × Clear all

NCT05534646 2026-02-02

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms